NeuroSense receives orphan drug designation from the European Medicines Agency (EMA), for the treatment of ALS patients with PrimeC.
Zebrafish Assist in the Battle Against ALS NeuroSense receives orphan drug designation from the European Medicines Agency (EMA), for the treatment of ALS patients with PrimeC.
Zebrafish Assist in the Battle Against ALS